114 related articles for article (PubMed ID: 22510495)
61. On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial.
Tian L; Cai T; Zhao L; Wei LJ
Biostatistics; 2012 Apr; 13(2):256-73. PubMed ID: 22294672
[TBL] [Abstract][Full Text] [Related]
62. Estimating causal effects using prior information on nontrial treatments.
Bond SJ; White IR
Clin Trials; 2010 Dec; 7(6):664-76. PubMed ID: 20817650
[TBL] [Abstract][Full Text] [Related]
63. Inverse probability weighting for covariate adjustment in randomized studies.
Shen C; Li X; Li L
Stat Med; 2014 Feb; 33(4):555-68. PubMed ID: 24038458
[TBL] [Abstract][Full Text] [Related]
64. Causal effect estimation strategies in a longitudinal study with complex time-varying confounders: A tutorial.
Mertens BJ; Datta S; Brand R; Peul W
Stat Methods Med Res; 2017 Feb; 26(1):337-355. PubMed ID: 25147227
[TBL] [Abstract][Full Text] [Related]
65. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.
Xie J; Liu C
Stat Med; 2005 Oct; 24(20):3089-110. PubMed ID: 16189810
[TBL] [Abstract][Full Text] [Related]
66. The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?
Baker SG; Kramer BS
BMC Med Res Methodol; 2002 Nov; 2():13. PubMed ID: 12429069
[TBL] [Abstract][Full Text] [Related]
67. Adjusted win ratio using the inverse probability of treatment weighting.
Wang D; Zheng S; Cui Y; He N; Chen T; Huang B
J Biopharm Stat; 2023 Nov; ():1-16. PubMed ID: 37947400
[TBL] [Abstract][Full Text] [Related]
68. Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules.
Bembom O; van der Laan MJ
Stat Med; 2008 Aug; 27(19):3689-716. PubMed ID: 18407580
[TBL] [Abstract][Full Text] [Related]
69. Identification of causal effects on binary outcomes using structural mean models.
Clarke PS; Windmeijer F
Biostatistics; 2010 Oct; 11(4):756-70. PubMed ID: 20522728
[TBL] [Abstract][Full Text] [Related]
70. Strategy for randomised clinical trials in rare cancers.
Tan SB; Dear KB; Bruzzi P; Machin D
BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
[TBL] [Abstract][Full Text] [Related]
71. Statistical methods for analyzing sequentially randomized trials.
Bembom O; van der Laan MJ
J Natl Cancer Inst; 2007 Nov; 99(21):1577-82. PubMed ID: 17971533
[TBL] [Abstract][Full Text] [Related]
72. ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials.
Grafféo N; Latouche A; Le Tourneau C; Chevret S
Comput Biol Med; 2019 Aug; 111():103339. PubMed ID: 31442762
[TBL] [Abstract][Full Text] [Related]
73. Inverse probability weighted estimation of the marginal odds ratio: correspondence regarding 'The performance of different propensity score methods for estimating marginal odds ratios'.
Forbes A; Shortreed S
Stat Med; 2008 Nov; 27(26):5556-9; author reply 5560-3. PubMed ID: 18613263
[No Abstract] [Full Text] [Related]
74. A novel estimand to adjust for rescue treatment in randomized clinical trials.
Michiels H; Sotto C; Vandebosch A; Vansteelandt S
Stat Med; 2021 Apr; 40(9):2257-2271. PubMed ID: 33567475
[TBL] [Abstract][Full Text] [Related]
75. On estimating average effects for multiple treatment groups.
Landsman V; Pfeiffer RM
Stat Med; 2013 May; 32(11):1829-41. PubMed ID: 23208873
[TBL] [Abstract][Full Text] [Related]
76. Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards.
Dehbi HM; Royston P; Hackshaw A
BMJ; 2017 May; 357():j2250. PubMed ID: 28546261
[TBL] [Abstract][Full Text] [Related]
77. Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two-stage stochastic dynamic treatment regime approach.
Hagiwara Y; Shinozaki T; Mukai H; Matsuyama Y
Biometrics; 2021 Jun; 77(2):702-714. PubMed ID: 32420624
[TBL] [Abstract][Full Text] [Related]
78. KMSubtraction: reconstruction of unreported subgroup survival data utilizing published Kaplan-Meier survival curves.
Zhao JJ; Syn NL; Tan BKJ; Yap DWT; Teo CB; Chan YH; Sundar R
BMC Med Res Methodol; 2022 Apr; 22(1):93. PubMed ID: 35369867
[TBL] [Abstract][Full Text] [Related]
79. The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts.
Zee J; Xie SX
Biostat Epidemiol; 2018; 2(1):23-33. PubMed ID: 30234179
[TBL] [Abstract][Full Text] [Related]
80. Estimating the Effect of Treatment Duration Using Observational Data in Practice.
van Geloven N; Dekkers OM; le Cessie S
Epidemiology; 2019 Mar; 30(2):e7-e8. PubMed ID: 30399000
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
